Sagimet Biosciences Inc.

NASDAQ: SGMT · Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT

Sagimet Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-45.57M -27.88M -30.5M -24.44M
Depreciation & Amortization
n/a n/a 130K 134K
Stock-Based Compensation
5.29M 4.99M 1.88M 1.9M
Other Working Capital
-141K -1.1M 4.21M -55K
Other Non-Cash Items
-1.11M 98K -215K 749K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.05M -978K 4.21M -55K
Operating Cash Flow
-42.44M -23.77M -24.49M -21.71M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-108.09M -19.62M -41.45M n/a
Sales Maturities Of Investments
46.4M 32.2M 9.44M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-61.68M 12.58M -32.01M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-931K -3.51M -85K -1.06M
Financial Cash Flow
104.82M 86.17M -73K 9.74M
Net Cash Flow
701K 74.98M -56.57M -11.97M
Free Cash Flow
-42.44M -23.77M -24.49M -21.71M